Exosome Diagnostics Receives $20,000,000 Series A Round

  • Feed Type
  • Date
    5/12/2010
  • Company Name
    Exosome Diagnostics
  • Mailing Address
    3960 Broadway New York, NY 10032
  • Company Description
    Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids.
  • Website
    http://www.ExosomeDX.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The purpose of the funding will be to further develop and commercialize a series of next-generation body fluid based oncology diagnostics through its proprietary, exosome based technology platform.
  • M&A Terms
  • Venture Investor
    NGN Capital
  • Venture Investor
    NGN Capital
  • Venture Investor
    Forbion Capital Partners

By posting a comment, you agree to our terms and conditions.